News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Lori Handy, MD, MSCE

Advertisement

Articles by Lori Handy, MD, MSCE

The changing landscape of RSV prevention | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

What has changed in the RSV prevention landscape?

ByLori Handy, MD, MSCE,Celeste Krewson, Assistant Editor
October 12th 2023

An abnormal surge in RSV was observed in the spring and fall 2022 seasons, but new immunizations offer protections previously unavailable.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary OB/GYN

    1

    FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

    2

    Barbara Levy, MD: Patient-collected hrHPV testing is "huge" part of updated cervical cancer guideline

    3

    Prenatal acid-suppressive medications not linked to neuropsychiatric disorders in offspring

    4

    RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression

    5

    Barbara Levy, MD, reacts to HRSA's updated cervical cancer guidelines

    • Advertise
    • Contact Us
    • Job Board
    • Terms of Use
    • Privacy Policy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us